Viewing Study NCT00407758


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2025-12-28 @ 11:13 PM
Study NCT ID: NCT00407758
Status: COMPLETED
Last Update Posted: 2019-03-20
First Post: 2006-12-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: GOG-0170J
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View